Imagine being able to take a blood test that detects your risks of developing Alzheimer’s, and then getting a pill to prevent the disease from ever taking hold of your brain. A collaboration between Seton and the Dell Medical School at The University of Texas at Austin seeks to make that vision a reality one day.
Seton and Dell Med have received a five-year grant from the Texas Council on Alzheimer’s Disease and Related Disorders to participate in a multi-site research program, called the Texas Alzheimer’s Research and Care Consortium (TARCC).
The first year of the grant awards Seton and Dell Med $800,000 to enroll 100 participants as part of the longitudinal observational study. Participants will undergo memory and blood testing. Researchers will use the results to analyze participants’ DNA and to detect potential biomarkers that may be linked to dementia.